Categories Earnings, Health Care

BioTelemetry Q2 earnings exceed estimates on record revenues; stock up 10%

Medical technology company BioTelemetry, Inc. (NASDAQ: BEAT) reported higher earnings and revenues for the June quarter. Earnings topped expectations, while revenues came in line with the forecast. The company’s stock gained about 10% following the announcement.

Adjusted earnings, excluding special items, moved up to $0.53 per share from $0.46 per share in the second quarter of 2018. Analysts had forecast a lower number. Reported profit was $8.3 million or $0.23 per share, compared to $10.4 million or $0.29 per share last year.

Also see: Mastercard Q2 profit, revenue top Street view

Driving the bottom-line growth, revenues advanced to $111.18 million in the second quarter from $101.36 million in the corresponding period of last year, setting a record. The top-line, which increased for 28th consecutive quarter, was broadly in line with the Street view. Growth was primarily driven by the stable demand for the company’s MCT and extended Holter services as well as the addition of the monitoring revenue from Geneva.

Growth was primarily driven by the stable demand for the company’s MCT and extended Holter services

“Our growth momentum continued in the second quarter, with revenue growth of 10%, enabling us to achieve the high end of our guidance.  This revenue growth was once again primarily driven by the strong demand for our MCT and extended Holter services as well as the addition of the monitoring revenue from Geneva, which we acquired in the first quarter,” said CEO Joseph Capper.

Also see: FireEye reports Q2 loss; stock plunges on weak guidance

In the March quarter, the company completed the acquisition of Geneva Healthcare, extending its remote cardiac monitoring reach to the implantable cardiac monitoring market. The deal is expected to reinforce the management’s growth strategy and provides significant revenue growth.

Shares of BioTelemetry hit a record high at the beginning of the year but lost momentum since then. The stock, which lost 25% so far this year, closed Tuesday’s regular session higher and continued to gain in the after-hours.

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

IPO Alert: Here’s what to look for when CaliberCos goes public

The massive slowdown in the IPO market continued in the second half as the challenges posed by high inflation and interest rate hikes weighed on investor confidence. Meanwhile, there is

CarMax (KMX) Stock: Does the current dip offer a buying opportunity?

The automotive sector is one of the worst affected by the combination of high inflation and rising interest rates. Consumers have become more cautious and are prioritizing their purchases with

Ultimax Digital gears up for $10mln IPO. Here’s all you need to know

The IPO market has witnessed muted activity this year, and things don’t seem to have improved in the second half. The upcoming public listing of video game technology firm Ultimax

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top